Immune therapy shows promise for asthma, heart disease—and even ageing
Making treatment quick and affordable will be the challenge
IN 2010 AN American girl called Emily Whitehead developed a form of leukaemia that is usually terminal. She was five years old. Two years later, she became the first paediatric patient to be offered a form of treatment called CAR-T, in which the body’s immune system is reprogrammed to attack cancerous cells. The treatment worked. A documentary film about her journey, released in 2022, was called “Of Medicine and Miracles”.
This article appeared in the Science & technology section of the print edition under the headline “When T-cells attack”
From the September 28th 2024 edition
Discover stories from this section and more in the list of contents
Explore the editionMore from Science & technology
Can you breathe stress away?
It won’t hurt to try. But scientists are only beginning to understand the links between the breath and the mind
The Economist’s science and technology internship
We invite applications for the 2025 Richard Casement internship
A better understanding of Huntington’s disease brings hope
Previous research seems to have misinterpreted what is going on
Is obesity a disease?
It wasn’t. But it is now
Volunteers with Down’s syndrome could help find Alzheimer’s drugs
Those with the syndrome have more of a protein implicated in dementia
Should you start lifting weights?
You’ll stay healthier for longer if you’re strong